Centene Corporation (LON:0HVB)
London · Delayed Price · Currency is GBP · Price in USD 40.18
+0.77 (1.95%)
Feb 12, 2026, 4:54 PM GMT
Centene Market Cap
Centene has a market cap or net worth of 14.57 billion as of February 12, 2026. Its market cap has decreased by -44.54% in one year.
Market Cap
14.57B
Enterprise Value
14.29B
Revenue
130.88B
Ranking
n/a
PE Ratio
n/a
Stock Price
40.18
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from 10.73M to 14.57B, an increase of 135,728.76%. That is a compound annual growth rate of 34.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 14.57B | -3.04% |
| Dec 31, 2025 | 15.03B | -38.49% |
| Dec 31, 2024 | 24.43B | -21.50% |
| Dec 29, 2023 | 31.12B | -19.25% |
| Dec 30, 2022 | 38.54B | 8.54% |
| Dec 31, 2021 | 35.51B | 39.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |